Genetic Similarities Between Latent Autoimmune Diabetes and Type 1 and Type 2 Diabetes

In this issue of Diabetes , Cervin et al. (1) investigated whether patients with latent autoimmune diabetes in adults (LADA) (defined as age at diabetes onset >35 years, GADA positive), analyzing known risk alleles for type 1 and type 2 diabetes, share genetic polymorphisms with type 1 diabetes (age at onset 35 years, GADA negative). In their LADA patients, they confirmed an increased frequency of type 1 diabetes–associated genetic risk factors including the heterozygous HLA-DQB1\*0201/\*0302 genotype, insulin AA genotype (rs689), and increased CT and TT genotypes of the PTPN22 gene (rs2476601) (2). Somewhat surprisingly, in LADA patients they also found a higher frequency of the type 2 diabetes–associated CT and TT genotypes of the TCF7L2 gene (rs7903146) (3), therefore concluding that LADA shares genetic features with both type 1 and type 2 diabetes. The article by Cervin et al. (1) uses the term LADA and immediately abandons the standard meaning of the term, instead equating LADA with GAD-positive patients who developed diabetes after age 35 years. LADA has been defined as the presence of GAD antibodies in patients with age of onset of diabetes after 35 years and insulin independence for at least 6 months after diagnosis (4–6). We agree with the authors in abandoning the standard definition of LADA and would agree with a number of other reviews that suggest one should abandon the term LADA altogether (7,8). A simpler alternative would be islet autoantibody–positive diabetes, which would likely come close to equating with type 1A diabetes, depending upon the …

[1]  L. Groop,et al.  Genetic Similarities Between Latent Autoimmune Diabetes in Adults, Type 1 Diabetes, and Type 2 Diabetes , 2008, Diabetes.

[2]  P. Pozzilli,et al.  The Protein Tyrosine Phosphatase Nonreceptor 22 (PTPN22) Is Associated With High GAD Antibody Titer in Latent Autoimmune Diabetes in Adults , 2007, Diabetes Care.

[3]  Marian Rewers,et al.  The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes , 2007, Proceedings of the National Academy of Sciences.

[4]  R. A. Bailey,et al.  Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes , 2007, Nature Genetics.

[5]  J. Ilonen,et al.  Circulating CD4+CD25high Regulatory T Cells and Natural Killer T Cells in Children with Newly Diagnosed Type 1 Diabetes or with Diabetes‐Associated Autoantibodies , 2007, Annals of the New York Academy of Sciences.

[6]  E. Zeggini,et al.  An association analysis of the HLA gene region in latent autoimmune diabetes in adults , 2006, Diabetologia.

[7]  J. Todd,et al.  Analysis of the type 2 diabetes gene, TCF7L2, in 13,795 type 1 diabetes cases and control subjects , 2006, Diabetologia.

[8]  G. Eisenbarth,et al.  Initial results of screening of nondiabetic organ donors for expression of islet autoantibodies. , 2006, The Journal of clinical endocrinology and metabolism.

[9]  A. Gottsäter,et al.  Latent autoimmune diabetes in adults: definition, prevalence, beta-cell function, and treatment. , 2005, Diabetes.

[10]  O. Rolandsson,et al.  Latent autoimmune diabetes in adults (LADA) should be less latent , 2005, Diabetologia.

[11]  E. Gale Latent autoimmune diabetes in adults: a guide for the perplexed , 2005, Diabetologia.

[12]  A. Hattersley,et al.  Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. , 2004, Diabetes.

[13]  M. Rewers,et al.  Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). , 2004, The Journal of clinical endocrinology and metabolism.

[14]  L. Romics,et al.  Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression. , 2003, Diabetes care.

[15]  A. Filipovich,et al.  Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome , 2002, Journal of medical genetics.

[16]  P. Fernlund,et al.  A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes. , 2002, Diabetes.

[17]  R. Holman,et al.  UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes , 1997, The Lancet.

[18]  H. Chase,et al.  Prediction of Type I Diabetes in First-Degree Relatives Using a Combination of Insulin, GAD, and ICA512bdc/IA-2 Autoantibodies , 1996, Diabetes.

[19]  J. Nerup,et al.  Incidence of Insulin‐dependent Diabetes Mellitus in Age Groups Over 30 years in Denmark , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[20]  L. Groop,et al.  Antibodies to Glutamic Acid Decarboxylase Reveal Latent Autoimmune Diabetes Mellitus in Adults With a Non—Insulin-Dependent Onset of Disease , 1993, Diabetes.

[21]  P. Pozzilli,et al.  The Protein Tyrosine Phosphatase Non Receptor 22 (PTPN22) is associated with high GAD antibody titre in latent autoimmune diabetes in adults (LADA) (NIRAD study 3) , 2007 .

[22]  L. Groop,et al.  Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. , 1999, Diabetes.